Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases-Reference-Cited by-同舟云学术

Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases

Published:2021-06-01 Issue:6 Volume:7 Page:845
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Chmura Steve¹,Winter Kathryn A.²,Robinson Clifford³,Pisansky Thomas M.⁴,Borges Virginia⁵,Al-Hallaq Hania¹,Matuszak Martha⁶,Park Sean S.⁴,Yi Sun⁷,Hasan Yasmin¹,Bazan Jose⁸,Wong Philip⁹,Yoon Harold A.¹⁰,Horton Janet¹¹,Gan Gregory¹²,Milano Michael T.¹³,Sigurdson Elin Ruth¹⁴,Moughan Jennifer²,Salama Joseph K.¹¹,White Julia⁸

Affiliation:

1. University of Chicago Comprehensive Cancer Center, Chicago, Illinois

2. NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania

3. Department of Radiation Oncology, Washington University in St Louis, St Louis, Missouri

4. Department of Medicine-Medical Oncology, Mayo Clinic, Rochester, Minnesota

5. University of Colorado-Anschutz Medical Center, Aurora

6. Department of Radiation Oncology, University of Michigan, Ann Arbor

7. Department of Radiation Oncology, University of Arizona Medical Center – University Campus, Tucson

8. Ohio State University Comprehensive Cancer Center, Columbus

9. Centre Hospitalier de L’Universite de Montréal, Hotel Dieu de Montréal, Montréal, Quebec, Canada

10. Heartland Cancer Research National Cancer Institute Community Oncology Research Program, Decatur, Illinois

11. Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina

12. New Mexico Minority Underserved National Cancer Institute Community Oncology Research Program, Albuquerque

13. Department of Radiation Oncology, University of Rochester, Rochester, New York

14. Fox Chase Cancer Center, Philadelphia, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2778658/jamaoncology_chmura_2021_oi_210007_1623352011.07963.pdf

Reference24 articles.

1. Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer.;Mok;N Engl J Med,2017

2. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.;Postow;N Engl J Med,2015

3. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.;Pastorino;J Thorac Cardiovasc Surg,1997

4. Liver resection for colorectal metastases.;Fong;J Clin Oncol,1997

5. Oligometastases.;Hellman;J Clin Oncol,1995

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Body Radiation Therapy to the Foot for Bone Metastasis;Advances in Radiation Oncology;2024-02

2. Safety and efficacy of radiotherapy combined with chemotherapy for recurrent metastatic renal pelvic and ureteral carcinoma;World Journal of Urology;2024-01-10

3. Predicting long‑term survival following involved site radiotherapy for oligometastases;Oncology Letters;2024-01-05

4. Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur);2023-12-23

5. Long-Term Results of a Phase 1 Dose Escalation Trial of Ablative Stereotactic Body Radiation Therapy;International Journal of Radiation Oncology*Biology*Physics;2023-12